Journal of Pharmaceutics & Drug Delivery ResearchISSN: 2325-9604

All submissions of the EM system will be redirected to Online Manuscript Submission System. Authors are requested to submit articles directly to Online Manuscript Submission System of respective journal.

Opinion Article, J Pharm Drug Deliv Res Vol: 12 Issue: 1

Advancements in Molecular Nanopharmaceutics: An Innovative Approach to Drug Delivery

Amin Mohamed*

Department of Biotechnology, Ramaiah University, Bengaluru, India

*Corresponding Author: Amin Mohamed
Department of Biotechnology, Ramaiah University, Bengaluru, India

Received date: 01 January, 2023, Manuscript No. JPDDR-23-95374;

Editor assigned date: 03 January, 2023, PreQC No. JPDDR-23-95374 (PQ);

Reviewed date: 17 January, 2023, QC No. JPDDR-23-95374;

Revised date: 24 January, 2023, Manuscript No. JPDDR-23-95374 (R);

Published date: 31 January, 2023, DOI: 10. 4172/2325-9604.1000213

Citation: Mohamed A (2023) Advancements in Molecular Nanopharmaceutics: An Innovative Approach to Drug Delivery. J Pharm Drug Deliv Res 12:1


The pharmaceutical industry has witnessed a paradigm shift in the last decade with the emergence of molecular nanopharmaceutics. This innovative approach has revolutionized drug delivery by providing enhanced therapeutic efficacy, targeted delivery, and reduced side effects. The technology involves the fabrication of nanoscale drug carriers that can encapsulate drugs and deliver them to the target site with high specificity.

Molecular nanopharmaceutics

Molecular nanopharmaceutics involve the fabrication of nanocarriers such as liposomes, polymeric nanoparticles, dendrimers, and carbon nanotubes that can encapsulate drugs and deliver them to the target site. The nanocarriers can protect the drugs from degradation, increase their solubility, and enhance their bioavailability. The size of the nanocarriers is essiential, as it determines their behavior in vivo. Small nanoparticles can easily penetrate tissues and accumulate in the target site, whereas larger nanoparticles can be phagocytosed by macrophages and accumulate in the liver and spleen.

Advantages of molecular nanopharmaceutics

The primary advantage of molecular nanopharmaceutics is targeted drug delivery. The nanocarriers can be engineered to specifically recognize and bind to receptors on the target cells. This targeted approach reduces off-target effects and improves therapeutic efficacy.

Additionally, the nanocarriers can protect the drugs from degradation, which improves their stability and bioavailability. The encapsulated drugs can also be released slowly over time, which reduces the frequency of dosing and improves patient compliance. Another advantage of molecular nanopharmaceutics is that it can overcome the blood-brain barrier, which is a major challenge in treating central nervous system disorders.

Applications of molecular nanopharmaceutic

Molecular nanopharmaceutics have a wide range of applications in medicine. One of the most significant applications is in cancer treatment. The targeted delivery of anticancer drugs to tumor cells can improve therapeutic efficacy and reduce off-target effects. The nanocarriers can also be functionalized with imaging agents, which can facilitate early diagnosis and monitoring of cancer. Another application of molecular nanopharmaceutics is in treating infectious diseases. Nanocarriers can encapsulate antibiotics and deliver them to the site of infection, which improves efficacy and reduces the development of antibiotic resistance. Molecular nanopharmaceutics also have potential applications in gene therapy, where the nanocarriers can deliver genetic material to the target cells.

Challenges of molecular nanopharmaceutics

Despite its advantages, molecular nanopharmaceutics face several challenges. One of the primary challenges is the toxicity of the nanocarriers. Some nanocarriers can induce an immune response or cause tissue damage, which limits their clinical use. The long-term safety of nanocarriers is also a concern, as they can accumulate in the body and cause toxicity over time. Another challenge is the scalability of nanocarrier production. The current methods of nanocarrier fabrication are complex and time-consuming, which limits their mass production. The cost of nanocarriers is also a concern, as they are more expensive than conventional drugs.


Molecular nanopharmaceutics are a promising approach to drug delivery that has the potential to revolutionize medicine. It offers targeted drug delivery, improved therapeutic efficacy, reduced side effects, and the ability to overcome biological barriers. While the technology is still in its start, it has already shown tremendous potential in preclinical studies. As researchers continue to overcome the challenges associated with molecular nanopharmaceutics, it is likely to become a essential tool in the fight against disease.

international publisher, scitechnol, subscription journals, subscription, international, publisher, science

Track Your Manuscript

Awards Nomination